Qlife to participate in investor presentations in September 2022

Qlife will participate in two investor days in September where the company's CEO Thomas Warthoe presents the company and gives his comments on recent events and upcoming activities.

September 26 at Stora Aktiedagen in Lund
Venue: Elite Hotel Ideon

Time: 08.30-09.00

The presentation will be held in English and the event is open to the public, as well as live-streamed and availalble on demand at https://www.youtube.com/Aktiespararna

September 27 at Redeye Theme Diagnostics (digital)
Venue: Redeye
Time: 09.10-09.30

The presentations will be held in English and is available live-streamed and availalble on demand for Redeye members at https://www.redeye.se/events/846227/redeye-theme-diagnostics

Investors, analysts and the media need to sign up for each event. The presentations will be available at each organizer.

For more information please contact:

Thomas Warthoe, CEO
tw@egoo.health
+45 21 63 35 34

Qlife is a medical device company born to challenge the status quo in healthcare. We work to shift the perspective and turn today's view on healthcare into tomorrow's focus on health- empowerment. We are on a quest to empower people with more accessible ways to understand their health - so that they can move beyond reactive care towards proactive wellbeing. It's how we contribute to improving quality of life for every individual and for the greater society.

Shares for Qlife are being traded on Nasdaq First North Growth Market in Stockholm with G&W Fondkommission as certified advisor (phone: +46 (0) 8-503 000 50, e-mail: ca@gwkapital.se).
Read more on Egoo.health, Qlifeholding.com or follow us on LinkedIn.